Arbutus Biopharma Corporation ABUS
4.06 USD +0.18 (+4.64%)
At closeNov 4, 2026, 5:03 PM EST
4.06 0.00 0.00%
After hours · Nov 4, 5:03 PM ET
3.87 Day range 4.08
3.50 52-week range 5.45
- YTD
- -15.59%
- 1 year
- -9.78%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 14.08M | 6.17M | 18.14M | 39.02M | 10.99M | |
| 14.08M | 6.17M | 18.14M | 39.02M | 10.99M | |
| -39.99M | -73.69M | -78.03M | -63.22M | -71.65M | |
| -33.50M | -69.92M | -72.85M | -69.46M | -76.25M | |
| -0.17 | -0.38 | -0.44 | -0.46 | -0.83 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 18.01M | 36.33M | 26.29M | 30.78M | 109.28M | |
| 94.62M | 131.71M | 144.40M | 195.42M | 204.49M | |
| 18.04M | 34.34M | 38.38M | 58.57M | 35.05M | |
| 4.19M | 6.12M | 8.72M | 12.55M | 18.91M | |
| 76.58M | 97.37M | 106.02M | 136.85M | 169.44M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -39.64M | -64.85M | -85.94M | -35.36M | -67.53M | |
| 15.58M | 22.95M | 50.77M | -74.94M | -12.68M | |
| 5.72M | 52.00M | 30.65M | 31.81M | 137.24M | |
| 364.00K | -182.00K | -988.00K | -512.00K | -809.00K | |
| -18.32M | 10.04M | -4.49M | -78.51M | 57.03M |